PHARMA SECTOR REQUESTS CHANGES TO EU GOOD DISTRIBUTION PRACTICE REFORMS
February 1st, 2012
BY KEITH NUTHALL
PHARMACEUTICAL major Bristol-Myers Squibb is among 85 mainly health-centred organisations requesting changes to the latest European Commission planned reforms to European Union (EU) pharmaceutical good distribution practice guidance. Commenting on proposals that medicinal products not intended for EU markets should be kept in segregated areas, BMS comments that "for supply chain efficiency, many companies ship their goods together. For example, products for Norway, Iceland, Switzerland and Russia, are stored with EU [products]." As ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.